Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Becton Dickinson &

09/08/2021 | 11:21am EDT


© MT Newswires 2021
All news about BECTON, DICKINSON AND COMPANY
10/19BECTON DICKINSON AND : BD Launches New 'Together We Advance' Environmental, Social, Govern..
AQ
10/18Becton, Dickinson Unveils ESG Strategy for 2030
DJ
10/18BECTON DICKINSON AND : BD Launches New 'Together We Advance' Environmental, Social, Govern..
PR
10/13BECTON DICKINSON AND : BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enh..
PU
10/07BECTON DICKINSON AND : Expands Capacity at Manufacturing Facility in Nebraska
MT
10/07BECTON DICKINSON AND : BD Announces 510(k) Clearance of Expanded Indications for the Rotar..
AQ
10/07BECTON DICKINSON AND : BD Unveils Nebraska-Based Manufacturing Capacity to Support U.S. Va..
PR
10/06BECTON DICKINSON AND : Receives FDA Clearance of Expanded Indications for Rotarex Atherect..
MT
10/06BECTON DICKINSON AND : BD Announces 510(k) Clearance of Expanded Indications for the Rotar..
PR
10/06Becton, Dickinson and Company Announces 510(k) Clearance of Expanded Indications for th..
CI
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Financials (USD)
Sales 2021 20 006 M - -
Net income 2021 2 231 M - -
Net Debt 2021 14 859 M - -
P/E ratio 2021 32,1x
Yield 2021 1,50%
Capitalization 70 907 M 70 907 M -
EV / Sales 2021 4,29x
EV / Sales 2022 4,31x
Nbr of Employees 72 000
Free-Float 78,2%
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 246,90 $
Average target price 270,20 $
Spread / Average Target 9,44%
EPS Revisions
Managers and Directors
Thomas E. Polen Chairman, President & Chief Executive Officer
Chris DelOrefice Chief Financial Officer & Executive Vice President
William R. Sigmund Chief Medical Officer & Executive Vice President
Jerry Flasz Chief Information Officer & EVP-Global Services
Elizabeth McCombs Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY-1.33%70 907
ABBOTT LABORATORIES12.62%218 606
MEDTRONIC PLC3.97%163 906
HOYA CORPORATION19.13%56 339
DEXCOM, INC.50.53%53 845
SARTORIUS STEDIM BIOTECH61.16%50 373